Global Anti-Parkinson Drugs Market Outlook Highlights Major Opportunities by 2025

The global anti-Parkinson drugs market is expected to grow from $5.3 billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.78 billion in 2025 at a CAGR of 9%.

The Business Research Company offers Anti-Parkinson Drugs Global Market Report 2021" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462

The anti-Parkinson drugs market consists of sales of drugs used for treating Parkinson's disease (PD), generated by the establishments that manufacture these drugs. Parkinson's disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems.

Some of the key players involved in the Anti-Parkinson Drugs Market are GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc., Mylan, Boehringer Ingelheim, Orion Pharma, ACADIA Pharmaceuticals Inc, Sun Pharma, Wockhardt, Dr. Reddy’s, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, Upsher-Smith, Lundbeck, Vertical Pharmaceuticals, LLC, Zambon Pharmaceuticals, M Somerset Pharmaceuticals Inc., Wockhardt.

The countries covered in the global Anti-Parkinson Drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Anti-Parkinson Drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Anti-Parkinson Drugs Market Segmentation:
By Drugs Class
1. Levodopa/Carbidopa
2. Dopamine Receptor Agonists
3. Monoamine Oxidase Type B (MAO-B) Inhibitors
4. Catechol-O-Methyltransferase (COMT)-inhibitors
5. Anticholinergics

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report-2020-30-covid-19-growth-and-change

A Few Points From The Table Of Contents
1. Executive Summary
2. Anti-Parkinson Drugs Market Characteristics
3. Anti-Parkinson Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Anti-Parkinson Drugs
5. Anti-Parkinson Drugs Market Size And Growth
……
26. Africa Anti-Parkinson Drugs Market
27. Anti-Parkinson Drugs Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market
29. Anti-Parkinson Drugs Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the Anti-Parkinson Drugs Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of this report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow our blog: http://blog.tbrc.info/

About Us:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.